Hairstetics Hair Implant Device Safety and Efficacy
Study Details
Study Description
Brief Summary
This is a prospective, single-arm, multi-center, international, open-label, non-randomized, clinical study.
The aim of the study is to assess the safety and efficacy of the use of the Hairstetics hair implant device in subjects affected with hair loss.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Hairstetics hair implant device Subjects will undergo the Hairstetics prosthetic hair implantation starting with a test of up to 100 fibers and up to 2 additional implantation sessions with up to 1500 fibers overall per subject. The implantation will be carried out according to the device IFU. |
Device: Hairstetics hair implant device
|
Outcome Measures
Primary Outcome Measures
- Acceptable number, duration and severity of expected adverse device/procedure effects [3 months following implantation]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Subject is ≥ 19 years old.
-
Subject has hair loss and has chosen to undergo synthetic hair implantation.
-
Subject has mental capacity to understand study guidelines and requirements (to maintain scalp hygiene, use of shampoo, delicate combing, etc.).
-
Subject has been evaluated by the investigator to have a scalp condition in the planned area of implantation that is acceptable for entering the study and currently is NOT suffering from skin problems at planned implantation site or elsewhere that might affect the procedure and/or success as clinically evaluated by the investigator.
-
Subject has Good general health.
-
Woman of child bearing potential must have a negative pregnancy test.
-
Subject willing to sign a written informed consent form (ICF) and the post implantation maintenance protocol.
Exclusion Criteria:
-
Previous synthetic hair implantation or hair transplantation in the past 6 months.
-
Currently suffering from skin problems at planned implantation site or elsewhere that might affect the procedure and/or success as clinically evaluated by the investigator.
-
Currently receiving or have within the past 3 months received radiation- and/or chemotherapy.
-
Currently using steroid product with Immunosuppressive treatment.
-
Impaired coagulation.
-
Serious illness that may affect subject compliance to protocol.
-
Subject is using illegal drugs.
-
Participating in other clinical study.
-
Known allergy or hypersensitivity to Nitinol or Nickel or Titanium
-
For woman: Pregnancy or breast feeding.
-
Known allergy or intolerance for the prescribed antibiotics and in such a case, a different antibiotics for which the subject is not allergic or intolerance to, will be prescribed
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Cabinet du Dr G. Beilin | Paris | France | ||
| 2 | Cabinet médical du Dr Jack Smadja | Paris | France | ||
| 3 | Georges Mandel Office Surgery Clinic | Paris | France | ||
| 4 | Paras hospital | Gurgaon | India | 122002 | |
| 5 | Fortis Hospital | New Delhi | India | 110088 | |
| 6 | Egoclinic | Bucharest | Romania | ||
| 7 | Metropolitan hospital | Bucharest | Romania | ||
| 8 | Revere clinic | London | United Kingdom | W1G7JA |
Sponsors and Collaborators
- Hairstetics
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HET-03